# Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit

> **NCT00844155** · NA · WITHDRAWN · sponsor: **University of Manitoba**

## Conditions studied

- Influenza A Virus Infection
- Influenza B Virus Infection

## Interventions

- **DRUG:** Oseltamivir 75 mg

## Key facts

- **NCT ID:** NCT00844155
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-03
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study has been withdrawn as the H1N1 epidemic made this study redundant
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00844155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00844155, "Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00844155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*